Listed Healthcare Companies Create Nearly 80,000 Jobs, Expanding Headcount by 48% Since 2019
A BTG Pactual survey shows ten listed healthcare companies increased their combined workforce from about 166,000…
Hypera Pharma is one of the largest drugmakers in Brazil, selling branded, generic and over-the-counter medicines.
HYPE3 is the ticker of Hypera Pharma’s common shares (ON) on B3, listed in the Novo Mercado, the segment with B3’s strictest corporate-governance rules.
Company facts: CVM open data (Formulário Cadastral 2026), available under the ODbL. Descriptions by Brazil Stock Guide.
A BTG Pactual survey shows ten listed healthcare companies increased their combined workforce from about 166,000…
After patent expiry in March 2026, Hypera (HYPE3) aims to be among the first to sell…
Drugmaker trims 2025 outlook, focuses on cash generation as debt costs weigh; eyes multibillion-real opportunity in…
Brazilian drugmaker's new semaglutide product captures more than 11% of the injectable market in its first…
Semavy, marketed under the Mantecorp brand, is expected to reach pharmacies within two months as Brazil…
Brazil’s Hypera Pharma (HYPE3.SA) reports 86.7% revenue jump and higher margins in Q1 2026, supported by…
Net revenue rises 16%, EBITDA margin back to pre-optimization levels; company redeems costlier debt and reinforces…
Pharma executives in Brazil this week; Lazard advising, O Globo reports.
Anvisa to fast-track semaglutide generics; EMS, Hypera and Biomm eye 2026 rollout.
HYPE3 is the ticker of Hypera Pharma’s common shares (ON) on B3, the São Paulo stock exchange, where the company is listed in the Novo Mercado, the segment with B3’s strictest corporate-governance rules.
Yes. Non-resident investors can buy shares listed on B3 through a Brazilian custodian after registering with the CVM, the Brazilian securities regulator.
The quote, chart, technical rating, company profile and financials on this page are TradingView widgets with B3 market data. The company facts come from the CVM public register, and the news from the Brazil Stock Guide newsroom.
Market data by TradingView. Informational only — not investment advice.